1 year return (CAGR)
-30.66%
Mineralys Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
MLYS
26.89
-2.51 (-8.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
34.96%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.38B
Price/Sales
-
Ent value
2.36B
Price/Book
4.32
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 29.36 |
| Daily high | 29.80 |
| Daily low | 26.62 |
| Daily Volume | 1.48M |
| All-time high | 47.33 |
| 1y analyst estimate | 48.50 |
| Beta | 0.68 |
| EPS (TTM) | -4.13 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MLYS | S&P500 | |
| Current price drop from All-time high | -43.19% | -1.29% |
| Highest price drop | -68.86% | -56.47% |
| Date of highest drop | 22 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -32.34% | -10.68% |
| Avg time to new high | 41 days | 12 days |
| Max time to new high | 626 days | 1805 days |
News
